Is Wolverine 10 mg or 20 mg?

Both are sold under the name. The 20 mg vial holds 10 mg of each component; the 10 mg vial holds 5 mg of each. A protocol quoted in units or in millilitres is meaningless without knowing which one it was written for.

Why is it called Wolverine?

Community coinage, after the Marvel character's healing. It is not a manufacturer's name, which is part of why the formulation was never standardised.

Is a blend better than two separate vials?

It is fewer injections and one price. Against that: the ratio is fixed, so you cannot adjust one component without the other; if you react you cannot tell which one caused it; and no published work has measured whether either peptide keeps its potency in shared solution.

Healing & recovery

Wolverine

Wolverine blend · BPC TB blend · BPC-157 TB-500 blend

PreclinicalProhibited in sportReviewed 25 Aug 2026

What is in the vial

The same name covers more than one vial. Pick the one you have — a dose in units written for one of these is wrong for the other.

20 mg vial — 10 mg of each
Compound	Per vial	Share	Bought separately
BPC-157Associated with angiogenesis in animal models.	10 mg	50%	$30–$35
TB-500Associated with cell migration through actin binding.	10 mg	50%	$35–$45
Total	20 mg		$65–$80

The more common of the two on US research sites.

The ratio is fixed in the vial: choosing a dose of one component chooses the dose of all the others. The separate-vials column is the cheapest confirmed listing to the median across vendors, for the masses this vial holds. We do not price blend vials themselves — hold it against whatever you are being quoted.

Wolverine is the repair backbone the other named blends are built on: BPC-157 and TB-500, nothing else. The name is community coinage after the Marvel character, not a manufacturer's.

It is sold in at least two sizes. A 20 mg vial with 10 mg of each is the more common; a 10 mg vial with 5 mg of each is widely sold too. Both are called Wolverine, so the name alone does not tell you what you have — read the vial, not the label on the forum post.

At 1:1 the arithmetic is easier than the GHK-Cu blends, where one component is five times the others. Choosing a dose still chooses both doses, but the two move together.

How it works

Two mechanisms arriving together, neither studied in combination.

BPC-157 is associated with angiogenesis in animal models: new blood supply to injured tissue.

TB-500 binds actin and is associated with cell migration, which is the step repair depends on after blood supply.

The stated rationale for pairing them is that they act at different points of the same process. No study has examined whether that holds.

Quick reference

Commonly described dose: 500 mcg–1 mg
How often: Daily, in courses of 4 to 8 weeks
Route: Subcutaneous
Where: Abdomen, Thigh, Near the injury site
Timing: No timing effect established for the mixture.
Storage once mixed: Refrigerated, 30 days

These describe what sources report, not what you should do. Full detail and provenance in the dosing section below.

Price index

Per-milligram pricing across vendors arrives with the directory. We are recording prices now so the history exists when the page ships.

Vocabulary on this page

Unit: A mark printed on an insulin syringe. A unit is not a fixed volume. What it represents depends entirely on the syringe's scale.
Blend: One vial containing several peptides at a fixed ratio, reconstituted and drawn together.
Vial: The small sealed glass container a peptide is sold in, holding a stated mass of freeze-dried powder under a rubber stopper.
Injection site: Where on the body an injection is given. Rotating between sites is standard practice for anything given repeatedly.
Peptide: A short chain of amino acids: the same building blocks as a protein, in a chain short enough to behave differently.

The whole glossary →

Regulatory status — United States

Not approved anywhere as a mixture or as either of its parts. Sold as a research chemical, in at least two vial sizes under the same name.

Last reviewed 25 Aug 2026. Regulatory positions in this category change frequently; we date this line so you can see how current it is.

What it is studied for

Each entry states the evidence behind it. We do not rank indications by effectiveness — for most compounds here, that would be a claim nobody can support.

Soft tissue and tendon repair

Published review

What the combination is sold for.

EvidenceNo study of the mixture exists. Both components are separately supported by animal work only.

Identity and clearance

Molecule

Class: Pre-mixed blend of two peptides, 1:1 by mass

A 20 mg vial is 10 mg of each. A 10 mg vial with 5 mg of each is also sold under the same name.

Dose protocols reported in sources

Displayed for reference only. Every row says where it came from, and a trial protocol and a community convention are not the same kind of information. None of this is fed into the calculator, and none of it is a recommendation.

Dose protocols reported in sources, with the source of each.
Goal	Dose	Frequency	Route	Units, 10 mg vial	Source	Start this protocol
Commonly described community protocol	500 mcg – 1 mg	Daily, in courses of 4 to 8 weeks	SubcutaneousTotal blend. At 1:1, 500 mcg of blend delivers 250 mcg each of BPC-157 and TB-500.	10–20 u	Community practice	Start this

Start this copies a row into a protocol of your own, which you can then edit. Where a source gave a dose range or an ambiguous frequency, those fields arrive empty — we will not pick a number on your behalf.

CheckRows marked community practice describe what people commonly do, drawn from public discussion. They are not derived from any trial and are not evidence that a dose is safe or effective.

Calculator

Work out what to draw

Pre-filled with a 20 mg vial as a worked example. These are not recommended values — change them to match the vial in front of you.

Draw to 5 units on a 1 mL U-100 syringe. That is 0.05 mL, containing 500 mcg of Wolverine.

Concentration10mg / mL

Volume drawn0.05mL

Doses per vial40doses

Per unit100mcg / unit

Check5 units falls between the printed lines on a 1 mL U-100 syringe. Mixing with 1.6 mL of water instead would put this dose at 4 units.

Get a shareable image Read the profile

Bioalmanac performs arithmetic on values you enter. It does not recommend doses, schedules or compounds, and nothing here is medical advice. Confirm every calculation against your vial and syringe before drawing, and speak with a licensed healthcare provider.

Open this calculation in the full calculator

Units, concentration, bacteriostatic water — the glossary defines the vocabulary, and a unit is not a fixed volume.

Safety

Reported effects

Everything from two compounds at oncePublished review
Unknown
No human study of the mixture. Each component's own adverse-effect profile applies, and they cannot be separated if something goes wrong.
Injection site reactionsCommunity practice
Commonly reported

When to stop

Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
An injection site that becomes hot, spreading or produces pus.
Any new or changing lump. Both components are associated with proliferation in animal models.

Interactions and situations that need care

Active or previous cancerAvoid
Both components are associated with angiogenesis or proliferation in animal models, and neither has been studied in anyone with a malignancy.
Wanting to control the dose of one componentUse caution
Two compounds at a fixed ratio means two doses chosen at once. Running them separately is the only way to dose them separately.
Competing in a tested sportAvoid
Components are WADA S2, prohibited at all times.

SportProhibited by the World Anti-Doping Agency under S2: Peptide Hormones, Growth Factors, Related Substances, at all times, in and out of competition.

What to expect

HonestlyThere is no human efficacy data for this compound, so there is no evidence-based timeline to give. Any site publishing a week-by-week schedule of expected effects has invented it.

No study of the mixture exists. Both components are animal-evidence only.
Two fixed doses chosen at once, though at 1:1 they move together.
Sold in at least two vial sizes under one name. Check which you have before calculating anything.
This is GLOW without the GHK-Cu, and KLOW without the GHK-Cu or the KPV.

Storage and handling

Freeze-dried powder: Refrigerated at 2–8 °C, protected from light.
After mixing: Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes both components with it.
Long-term, frozen: Unopened powder is stable at −20 °C or colder.

Printable one-pager How to reconstitute a vial, step by step

With other peptides

GLOWcaution
GLOW contains both of these plus GHK-Cu. Running both means taking BPC-157 and TB-500 twice.
KLOWcaution
KLOW contains both of these plus GHK-Cu and KPV. Running both means taking BPC-157 and TB-500 twice.
Klowverinecaution
Klowverine contains both of these at 20 mg each. Running both doubles them again.
Deadpoolcaution
Deadpool contains both of these plus KPV. Running both means taking BPC-157 and TB-500 twice.

Check this against a whole stack

Checking your vial

Research chemicals carry no manufacturing standard, so what the vial looks like is often the only quality signal available before you use it. More on assessing quality and COAs.

Clear and colourless after reconstitution
Unlike the GHK-Cu blends, nothing here is blue. A blue Wolverine vial is not Wolverine.
Cloudiness or visible particles
Discard it.
No stated vial size
10 mg and 20 mg vials are both sold as Wolverine. Without the size, no dose can be calculated.

Questions

Is Wolverine 10 mg or 20 mg?: Both are sold under the name. The 20 mg vial holds 10 mg of each component; the 10 mg vial holds 5 mg of each. A protocol quoted in units or in millilitres is meaningless without knowing which one it was written for.
Why is it called Wolverine?: Community coinage, after the Marvel character's healing. It is not a manufacturer's name, which is part of why the formulation was never standardised.
Is a blend better than two separate vials?: It is fewer injections and one price. Against that: the ratio is fixed, so you cannot adjust one component without the other; if you react you cannot tell which one caused it; and no published work has measured whether either peptide keeps its potency in shared solution.

References

Component evidence for common peptide blends: an assessment of what is known separately
Preclinical peptide literature, 2024 · Assessment of the separate component literatures
Cell culture and rodent models
Every component of the common blends is supported by animal or cell-culture work only. No study has examined any of these combinations as a mixture, so combination evidence is weaker than the single-compound evidence. That is itself preclinical.
Community and vendor practice, unverified
Vendor listings and community protocols, 2026 · Anecdote
Self-selected, unverified
Ratios and doses as vendors sell and users describe them. Ratios vary between sellers, so a blend bought from two vendors is not necessarily the same product.

Related compounds

GLOW

A pre-mixed vial of GHK-Cu, BPC-157 and TB-500 at 5:1:1. One draw delivers all three, in proportions most people underestimate.

KLOW

GLOW with KPV added: four compounds in one vial at 5:1:1:1. The newest and least studied of the common blends.

Klowverine

KLOW with the three repair peptides doubled: 50 mg GHK-Cu with 20 mg each of BPC-157, TB-500 and KPV. The least documented of the named blends.

Deadpool

Wolverine with KPV added and the ratio tilted toward TB-500: 10 mg TB-500 with 5 mg each of BPC-157 and KPV. Documented at a single vendor.

Keep this page honest

If something here is wrong, out of date, or missing a source, tell us and we will fix it and say that we did.

Suggest a correction

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice. No clinician reviews these pages.

Page last updated 25 Aug 2026